Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
European Journal of Nutrition
|
March 19, 2017
Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat
Roberto Coccurello, Adele Romano, Giacomo Giacovazzo, et al.
Oncotarget
|
May 11, 2017
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score
Rossana Cocchiola, Donatella Romaniello, Caterina Grillo, et al.
Journal of Neurochemistry
|
June 14, 2022
ERp57 chaperon protein protects neuronal cells from Aβ-induced toxicity
Daniel Di Risola, Daniela Ricci, Ilaria Marrocco, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 15, 2019
Clustering of IRE1α depends on sensing ER stress but not on its RNase activity
Daniela Ricci, Ilaria Marrocco, Daniel Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2018
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways
Donatella Romaniello, Luigi Mazzeo, Maicol Mancini, et al.
EMBO Molecular Medicine
|
March 4, 2021
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
Ilaria Marrocco, Donatella Romaniello, Itay Vaknin, et al.
Cancer Research
|
May 4, 2021
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors
Yuya Haga, Ilaria Marrocco, Ashish Noronha, et al.
Cells
|
September 11, 2019
Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism
Ilaria Marrocco, Fabio Altieri, Elisabetta Rubini, et al.
Cell Reports. Medicine
|
August 9, 2023
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab
Ilaria Marrocco, Suvendu Giri, Arturo Simoni-Nieves, et al.
Cell Reports. Medicine
|
August 31, 2024
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib
Arturo Simoni-Nieves, Moshit Lindzen, Suvendu Giri, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
European Journal of Nutrition
|
March 19, 2017
Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat
Roberto Coccurello, Adele Romano, Giacomo Giacovazzo, et al.
Oncotarget
|
May 11, 2017
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score
Rossana Cocchiola, Donatella Romaniello, Caterina Grillo, et al.
Journal of Neurochemistry
|
June 14, 2022
ERp57 chaperon protein protects neuronal cells from Aβ-induced toxicity
Daniel Di Risola, Daniela Ricci, Ilaria Marrocco, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 15, 2019
Clustering of IRE1α depends on sensing ER stress but not on its RNase activity
Daniela Ricci, Ilaria Marrocco, Daniel Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2018
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways
Donatella Romaniello, Luigi Mazzeo, Maicol Mancini, et al.
EMBO Molecular Medicine
|
March 4, 2021
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
Ilaria Marrocco, Donatella Romaniello, Itay Vaknin, et al.
Cancer Research
|
May 4, 2021
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors
Yuya Haga, Ilaria Marrocco, Ashish Noronha, et al.
Cells
|
September 11, 2019
Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism
Ilaria Marrocco, Fabio Altieri, Elisabetta Rubini, et al.
Cell Reports. Medicine
|
August 9, 2023
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab
Ilaria Marrocco, Suvendu Giri, Arturo Simoni-Nieves, et al.
Cell Reports. Medicine
|
August 31, 2024
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib
Arturo Simoni-Nieves, Moshit Lindzen, Suvendu Giri, et al.
Page
of 3